Sinibaldi VJ - Search Results

1

A prospective study of suramin-induced peripheral neuropathy.

Chaudhry V, Eisenberger MA, Sinibaldi VJ, Sheikh K, Griffin JW, Cornblath DR. Chaudhry V, et al. Among authors: sinibaldi vj. Brain. 1996 Dec;119 ( Pt 6):2039-52. doi: 10.1093/brain/119.6.2039. Brain. 1996. PMID: 9010008 Clinical Trial.

2

Development and validation of a pharmacokinetically based fixed dosing scheme for suramin.

Reyno LM, Egorin MJ, Eisenberger MA, Sinibaldi VJ, Zuhowski EG, Sridhara R. Reyno LM, et al. Among authors: sinibaldi vj. J Clin Oncol. 1995 Sep;13(9):2187-95. doi: 10.1200/JCO.1995.13.9.2187. J Clin Oncol. 1995. PMID: 7666077 Clinical Trial.

3

Suramin: development of a population pharmacokinetic model and its use with intermittent short infusions to control plasma drug concentration in patients with prostate cancer.

Jodrell DI, Reyno LM, Sridhara R, Eisenberger MA, Tkaczuk KH, Zuhowski EG, Sinibaldi VJ, Novak MJ, Egorin MJ. Jodrell DI, et al. Among authors: sinibaldi vj. J Clin Oncol. 1994 Jan;12(1):166-75. doi: 10.1200/JCO.1994.12.1.166. J Clin Oncol. 1994. PMID: 8270974 Clinical Trial.

4

Suramin, an active drug for prostate cancer: interim observations in a phase I trial.

Eisenberger MA, Reyno LM, Jodrell DI, Sinibaldi VJ, Tkaczuk KH, Sridhara R, Zuhowski EG, Lowitt MH, Jacobs SC, Egorin MJ. Eisenberger MA, et al. Among authors: sinibaldi vj. J Natl Cancer Inst. 1993 Apr 21;85(8):611-21. doi: 10.1093/jnci/85.8.611. J Natl Cancer Inst. 1993. PMID: 8468719 Clinical Trial.

5

Evaluation of prostate-specific antigen as a surrogate marker for response of hormone-refractory prostate cancer to suramin therapy.

Sridhara R, Eisenberger MA, Sinibaldi VJ, Reyno LM, Egorin MJ. Sridhara R, et al. Among authors: sinibaldi vj. J Clin Oncol. 1995 Dec;13(12):2944-53. doi: 10.1200/JCO.1995.13.12.2944. J Clin Oncol. 1995. PMID: 8523059

6

Ocular symptoms and signs associated with suramin sodium treatment for metastatic cancer of the prostate.

Hemady RK, Sinibaldi VJ, Eisenberger MA. Hemady RK, et al. Among authors: sinibaldi vj. Am J Ophthalmol. 1996 Mar;121(3):291-6. doi: 10.1016/s0002-9394(14)70277-6. Am J Ophthalmol. 1996. PMID: 8597272

7

Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer.

Eisenberger MA, Sinibaldi VJ, Reyno LM, Sridhara R, Jodrell DI, Zuhowski EG, Tkaczuk KH, Lowitt MH, Hemady RK, Jacobs SC, et al. Eisenberger MA, et al. Among authors: sinibaldi vj. J Clin Oncol. 1995 Sep;13(9):2174-86. doi: 10.1200/JCO.1995.13.9.2174. J Clin Oncol. 1995. PMID: 7666076 Clinical Trial.

8

Evaluation of biomarkers of survival response in hormone-refractory prostate cancer patients treated with suramin.

Sridhara R, Eisenberger MA, Sinibaldi VJ, Reyno LM, Egorin MJ. Sridhara R, et al. Among authors: sinibaldi vj. Cancer Epidemiol Biomarkers Prev. 1998 Jul;7(7):631-4. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9681533

9

Preliminary evaluation of a short course of estramustine phosphate and docetaxel (Taxotere) in the treatment of hormone-refractory prostate cancer.

Sinibaldi VJ, Carducci M, Laufer M, Eisenberger M. Sinibaldi VJ, et al. Semin Oncol. 1999 Oct;26(5 Suppl 17):45-8. Semin Oncol. 1999. PMID: 10604269 Clinical Trial.

10

Rapid disease progression after the administration of bicalutamide in patients with metastatic prostate cancer.

Laufer M, Sinibaldi VJ, Carducci MA, Eisenberger MA. Laufer M, et al. Among authors: sinibaldi vj. Urology. 1999 Oct;54(4):745. doi: 10.1016/s0090-4295(99)00268-x. Urology. 1999. PMID: 10754148 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters